Iluka Resources Ltd (ILU)
Australian Securities Exchange · Australia · prices in AUD · close of 19 Oct 2026
Key indicators
| Last close | AUD 5.230 |
|---|---|
| 52-week range | 4.876 – 8.653 |
| Return, 1 month / 3 months | −13.7% / −14.3% |
| Return, 1 year / 3 years | −30.1% / −21.4% |
| Trend | Below its 200-day average |
| RSI (14) | 33 |
| Volatility (1 year) | 52.8% |
| Worst drawdown (1 year) | -40.6% |
| Average daily value traded | 13.12M AUD |
| Dividend yield | 1.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Iluka Resources is an Australian mineral sands company that mines and processes heavy mineral sands. It produces zircon, used in ceramics and refractories, and titanium dioxide feedstocks such as rutile and synthetic rutile, which are used to make pigments and other products. Its customers are industrial manufacturers in ceramics, pigments and related sectors. The company is based in Perth, Western Australia, and operates mineral sands deposits and processing facilities in Australia and elsewhere.
Iluka Resources Ltd trades under the code ILU on the Australian Securities Exchange in Australia, with its price quoted in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Iluka Resources Ltd (ILU) trades on the Australian Securities Exchange in Australia. It last closed at AUD 5.230 on 19 October 2026.
Its price-based Market X-Ray is 56 out of 100 (a fair price profile), ranking 767 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 30.1% and over the last three months it fell 14.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 49 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -21.9% | ||
| From 52-week high | -38.6% | ||
| Momentum | 37 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -14.3% | ||
| 6-month return | -31.5% | ||
| 12-month return, skipping the last month | -19.0% | ||
| Stability (higher is calmer) | 70 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 52.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -40.6% | ||
| Liquidity | 93 · Strong | Trades actively. | |
| Average daily value traded | 13.12M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | 30 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.1% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | −4.2% |
|---|---|
| 1 month | −13.7% |
| 3 months | −14.3% |
| 6 months | −31.5% |
| 1 year | −30.1% |
| 3 years | −21.4% |
| 5 years | −36.8% |
Signals
| 50-day / 200-day average | 6.345 / 6.693 |
|---|---|
| Golden / death cross (60 days) | Death, 35 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.223 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 31 Aug 2026 | AUD 0.0300 |
| 5 Mar 2026 | AUD 0.0300 |
| 2 Sep 2025 | AUD 0.0200 |
| 4 Mar 2025 | AUD 0.0400 |
| 3 Sep 2024 | AUD 0.0400 |
| 5 Mar 2024 | AUD 0.0400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.